147 related articles for article (PubMed ID: 38127882)
1. Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study.
da Silva JL; de Souza BSW; de Albuquerque LZ; Aleixo SB; Resende GADS; de Oliveira DGB; Dos Santos EN; Nogueira-Rodrigues A; Clara RO; Gaui MFD; Mota ACA; de Lima VCC; Rosa DD; Munhoz RR; Morbeck IAP; Gelatti ACZ; Mathias CMC; de Melo AC
PLoS One; 2023; 18(12):e0295597. PubMed ID: 38127882
[TBL] [Abstract][Full Text] [Related]
2. Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute.
de Melo AC; Thuler LCS; da Silva JL; de Albuquerque LZ; Pecego AC; Rodrigues LOR; da Conceição MS; Garrido MM; Quintella Mendes GL; Mendes Pereira ACP; Soares MA; Viola JPB;
PLoS One; 2020; 15(10):e0241261. PubMed ID: 33104715
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
Borno HT; Kim MO; Hong JC; Yousefi S; Lin A; Tolstykh I; Zhang S; McKay RR; Harismendy O; Cinar P; Rugo H; Koshkin VS; Rabow M; Wang C; Bailey A; Small EJ
Oncologist; 2022 May; 27(5):398-406. PubMed ID: 35348771
[TBL] [Abstract][Full Text] [Related]
4. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
[TBL] [Abstract][Full Text] [Related]
5. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
[TBL] [Abstract][Full Text] [Related]
6. Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems.
Hwang C; Izano MA; Thompson MA; Gadgeel SM; Weese JL; Mikkelsen T; Schrag A; Teka M; Walters S; Wolf FM; Hirsch J; Rivera DR; Kluetz PG; Singh H; Brown TD
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1388. PubMed ID: 34014037
[TBL] [Abstract][Full Text] [Related]
7. Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: Evaluating the role of socio-demographic factors and comorbidities.
Young-Wolff KC; Slama N; Sakoda LC; Prochaska JJ; Fogelberg R; Alexeeff SE
Prev Med; 2023 Jul; 172():107523. PubMed ID: 37116761
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities.
Johnston EE; Martinez I; Davis ES; Caudill C; Richman J; Brackett J; Dickens DS; Kahn A; Schwalm C; Sharma A; Patel PA; Bhatia S; Levine JM; Wolfson JA;
J Clin Oncol; 2021 Dec; 39(34):3778-3788. PubMed ID: 34694886
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic factors associated with COVID-19 in-hospital mortality in Brazil.
Peres IT; Bastos LSL; Gelli JGM; Marchesi JF; Dantas LF; Antunes BBP; Maçaira PM; Baião FA; Hamacher S; Bozza FA
Public Health; 2021 Mar; 192():15-20. PubMed ID: 33607516
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry.
Marcolino MS; Ziegelmann PK; Souza-Silva MVR; Nascimento IJB; Oliveira LM; Monteiro LS; Sales TLS; Ruschel KB; Martins KPMP; Etges APBS; Molina I; Polanczyk CA;
Int J Infect Dis; 2021 Jun; 107():300-310. PubMed ID: 33444752
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
15. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of 1544 Brazilians aged 60 years and over with laboratory evidence for SARS-CoV-2.
Nascimento MM
Arch Gerontol Geriatr; 2021; 96():104462. PubMed ID: 34175730
[TBL] [Abstract][Full Text] [Related]
18. Characterization of demographic data, clinical signs, comorbidities, and outcomes according to the race in hospitalized individuals with COVID-19 in Brazil: An observational study.
Sansone NM; Boschiero MN; Valencise FE; Palamim CV; Marson FA
J Glob Health; 2022 Jul; 12():05027. PubMed ID: 35871427
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study.
Castro MC; Gurzenda S; Macário EM; França GVA
BMJ Open; 2021 May; 11(5):e049089. PubMed ID: 33947740
[TBL] [Abstract][Full Text] [Related]
20. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
